PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,244,563 | +457.5% | 365,564 | +468.4% | 0.00% | – |
| Q2 2023 | $402,644 | +46.3% | 64,320 | +11.5% | 0.00% | – |
| Q1 2023 | $275,243 | -72.7% | 57,703 | -50.3% | 0.00% | -100.0% |
| Q4 2022 | $1,009,600 | -67.7% | 116,046 | -55.9% | 0.00% | -50.0% |
| Q3 2022 | $3,129,000 | -57.9% | 262,910 | -49.5% | 0.00% | -66.7% |
| Q2 2022 | $7,425,000 | +1175.8% | 521,055 | +1762.6% | 0.01% | – |
| Q1 2022 | $582,000 | -74.5% | 27,974 | -71.7% | 0.00% | -100.0% |
| Q4 2021 | $2,281,000 | +42.0% | 98,738 | +83.2% | 0.00% | 0.0% |
| Q3 2021 | $1,606,000 | -12.1% | 53,885 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,827,000 | +68.2% | 53,479 | +62.0% | 0.00% | 0.0% |
| Q1 2021 | $1,086,000 | +587.3% | 33,020 | +1182.3% | 0.00% | – |
| Q4 2020 | $158,000 | – | 2,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |